Article
Ankylosing spondylitis: From pathogenesis to therapy.
International immunopharmacology - 3 Jan 2025
Wei Yuxiao, Zhang Shuqiong, Shao Fenli, Sun Yang
Abstract excerpt
Ankylosing spondylitis (AS) is an autoimmune rheumatic disease that primarily affects the axial joints, with its etiology complex and still not fully understood. The unknown pathogenesis of AS limits the development of treatment strategies, so keeping up-to-date with the current research on AS can help in searching for potential therapeutic targets. In addition to the classic HLA-B27 genetic susceptibility and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
